Skip to main content
. 2020 Jul 28;10(3):915–925. doi: 10.3233/JPD-202010

Fig. 2.

Fig. 2

Selected Efficacy Outcome Measures. *denotes p-value <0.05 and statistically significant difference in the ER group as compared to the IR group. **denotes p-value <0.01 and statistically significant difference in the ER group as compared to the IR group. EOS, End of Study; ER, extended release; IR, immediate release; PGI-C, Patient Global Impression of Change; UPDRS, Unified Parkinson’s Disease Rating Scale.